Insight Molecular Diagnostics INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersNashville, TN
SAM.gov UEIWSM4QVJ3E787
iMDx develops diagnostic products for the transplant and oncology industries. The company makes GraftAssureCore, a dd-cfDNA solution for post-transplant monitoring, and GraftAssureIQ, a dd-cfDNA assay for research use. Additional products including GraftAssureDx, DetermaCNI, DetermaIO, and OncoTIME are in development or coming soon.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Insight Molecular Diagnostics INC | Nashville | TN | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.